Abstract
Amyloid beta peptide (Aβ) is implicated in the pathogenesis of Alzheimers disease (AD), particularly as oligomers or polymers that are correlated with Ab cellular toxicity. Inhibition of the formation of toxic forms of Aβ has therefore emerged as one approach to the treatment of AD. This article reviews efforts to adapt the structure of Aβ to the design and testing of peptide-based inhibitors of Aβ polymerization of interest as potential AD therapeutics.
Keywords: Peptide Inhibitors, Beta Amyloid Aggregation, Amyloid beta peptide
Current Topics in Medicinal Chemistry
Title: Peptide Inhibitors of Beta Amyloid Aggregation
Volume: 2 Issue: 4
Author(s): Mark A. Findeis
Affiliation:
Keywords: Peptide Inhibitors, Beta Amyloid Aggregation, Amyloid beta peptide
Abstract: Amyloid beta peptide (Aβ) is implicated in the pathogenesis of Alzheimers disease (AD), particularly as oligomers or polymers that are correlated with Ab cellular toxicity. Inhibition of the formation of toxic forms of Aβ has therefore emerged as one approach to the treatment of AD. This article reviews efforts to adapt the structure of Aβ to the design and testing of peptide-based inhibitors of Aβ polymerization of interest as potential AD therapeutics.
Export Options
About this article
Cite this article as:
Findeis A. Mark, Peptide Inhibitors of Beta Amyloid Aggregation, Current Topics in Medicinal Chemistry 2002; 2 (4) . https://dx.doi.org/10.2174/1568026024607508
DOI https://dx.doi.org/10.2174/1568026024607508 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Predictors of Conversion to Dementia of Probable Alzheimer Type in Patients with Mild Cognitive Impairment
Current Alzheimer Research Functional Food with Some Health Benefits, So Called Superfood: A Review
Current Nutrition & Food Science Monoclonal Antibodies: A Target Therapy for Multiple Sclerosis
Inflammation & Allergy - Drug Targets (Discontinued) Adverse Drug Reaction Reporting Related to the Administration of Antibiotics in Hospitalized Pediatric Patients in Greece
Current Drug Safety Renal Tubular Acidosis
Current Pediatric Reviews Cholesterol Metabolism and Brain Amyloidosis: Evidence for a Role of Copper in the Clearance of A β Through the Liver
Current Alzheimer Research Genetic and Epigenetic Alterations in Pancreatic Carcinogenesis
Current Genomics Editorial (Thematic Issue: Statistical Signal Processing in the Analysis, Characterization and Detection of Alzheimer's Disease)
Current Alzheimer Research The Potentials of Selected Therapeutic Targets for Inflammation: A Snapshot
Recent Patents on Inflammation & Allergy Drug Discovery From Substance Dependence to Addiction: Impact of a Conceptual Shift on Therapeutic Approaches?
Current Pharmaceutical Design Electromagnetic Fields Act Similarly in Plants as in Animals: Probable Activation of Calcium Channels via Their Voltage Sensor
Current Chemical Biology The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Current Drug Targets Childhood Hospitalisations for Physical Disease and Risk of Mental Disorders During Adolescence and Early Adulthood
Adolescent Psychiatry Smoking, Estradiol Metabolism and Hormone Replacement Therapy
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Growing up in the Web of Social Networking: Adolescent Development and Social Media
Adolescent Psychiatry Inflammation and Parkinsons Disease
Current Drug Targets - Inflammation & Allergy Significant Association of CXCL12 rs1746048 with LDL-C Level in Intracranial Aneurysms
Current Neurovascular Research Salidroside - Can it be a Multifunctional Drug?
Current Drug Metabolism The Potential of Caffeine for Functional Modification from Cortical Synapses to Neuron Networks in the Brain
Current Neuropharmacology Development of Cinnarizine Microballoons by Sequential Optimization and <i>In Vivo</i> Imaging by Gamma Scintigraphy
Current Drug Therapy